Difference between revisions of "LncRNAWiki:Melanoma"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Name !width="50"|Transcript ID !width="50"|Alias !width="50"|Description !width="50"|Disease |-...") |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 6: | Line 6: | ||
!width="50"|Description | !width="50"|Description | ||
!width="50"|Disease | !width="50"|Disease | ||
| + | |- | ||
| + | |''CDKN2B-AS1'' | ||
| + | |[[NONHSAT130421]],[[lnc-C9orf53-2:1]] | ||
| + | |ANRIL, p15AS, ENSG00000240498 | ||
| + | |CDKN2B antisense RNA 1 | ||
| + | |melanoma | ||
| + | |- | ||
| + | |''GAS5'' | ||
| + | |[[NONHSAT007663]] | ||
| + | |SNHG2, ENSG00000234741 | ||
| + | |_ | ||
| + | |autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus | ||
|- | |- | ||
|''H19'' | |''H19'' | ||
| Line 13: | Line 25: | ||
|"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" | |"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" | ||
|- | |- | ||
| − | |'' | + | |''SPRY4-IT1'' |
| − | |[[ | + | |[[lnc-NDFIP1-3:1]] |
| − | | | + | |AK024556, ENSG00000274721 |
| − | | | + | |SPRY4 intronic transcript 1 (non-protein coding) |
| − | | | + | |melanoma |
| + | |- | ||
| + | |''DRAIC'' | ||
| + | |[[DRAIC]] | ||
| + | |N/A | ||
| + | |"downregulated RNA in cancer, inhibitor of cell invasion and migration" | ||
| + | |"prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma" | ||
| + | |- | ||
| + | |''SAMMSON'' | ||
| + | |[[SAMMSON]] | ||
| + | |N/A | ||
| + | |survival associated mitochondrial melanoma specific oncogenic non-coding RNA | ||
| + | |melanoma | ||
| + | |- | ||
| + | |''MHENCR'' | ||
| + | |[[MHENCR]] | ||
| + | |N/A | ||
| + | |melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 | ||
| + | |melanoma | ||
| + | |- | ||
| + | |''LINC00888'' | ||
| + | |[[LINC00888]] | ||
| + | |N/A | ||
| + | |long intergenic non-protein coding RNA 888 | ||
| + | |melanoma tumorigenesis | ||
| + | |- | ||
| + | |''MIR200CHG'' | ||
| + | |[[MIR200CHG]] | ||
| + | |U47924.27 | ||
| + | |MIR200C and MIR141 host gene | ||
| + | |melanoma tumorigenesis | ||
| + | |- | ||
| + | |''SPINT1-AS1'' | ||
| + | |[[SPINT1-AS1]] | ||
| + | |RP11-532F12.5 | ||
| + | |SPINT1 antisense RNA 1 | ||
| + | |melanoma tumorigenesis | ||
|} | |} | ||
Latest revision as of 08:46, 28 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | ANRIL, p15AS, ENSG00000240498 | CDKN2B antisense RNA 1 | melanoma |
| GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus |
| H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" |
| SPRY4-IT1 | lnc-NDFIP1-3:1 | AK024556, ENSG00000274721 | SPRY4 intronic transcript 1 (non-protein coding) | melanoma |
| DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | "prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma" |
| SAMMSON | SAMMSON | N/A | survival associated mitochondrial melanoma specific oncogenic non-coding RNA | melanoma |
| MHENCR | MHENCR | N/A | melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 | melanoma |
| LINC00888 | LINC00888 | N/A | long intergenic non-protein coding RNA 888 | melanoma tumorigenesis |
| MIR200CHG | MIR200CHG | U47924.27 | MIR200C and MIR141 host gene | melanoma tumorigenesis |
| SPINT1-AS1 | SPINT1-AS1 | RP11-532F12.5 | SPINT1 antisense RNA 1 | melanoma tumorigenesis |
